Myocardial Infarction Register of the Saarland (MIR-SL)

April 11, 2023 updated by: Stiftung Institut fuer Herzinfarktforschung

Myokardinfarkt-Register Des Saarlandes (MIR-SL)

The Myocardial Infarction Register Saarland (MIR-SL), is intended to collect data about the treatment of patients suffering from ST-elevation myocardial infarction (STEMI). It aims to provide current data on the implementation of guidelines for both, the interventional and adjuvant drug therapy of STEMI in daily clinical practice in the Saarland.

Study Overview

Status

Completed

Conditions

Detailed Description

The Myocardial Infarction Register Saarland (MIR-SL), is intended to collect data about the treatment of patients suffering from ST-elevation myocardial infarction (STEMI). It aims to provide current data on the implementation of guidelines for both, the interventional and adjuvant drug therapy of STEMI in daily clinical practice in the Saarland.

In order to obtain representative data for the Saarland, preferably all consecutive patients should be documented comprehensively in the University Hospital of the Saarland, the non-university hospitals with cardiac catheterization laboratory as well as in hospitals without cardiac catheterization laboratory .

MIR-SL is attended by all 22 hospitals in Saarland, that treat patients with acute STEMI. A follow-up will be carried out after three months, 12 months and five years.

Study Type

Observational

Enrollment (Actual)

455

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
      • Dillingen, Germany
        • Marienhaus Klinikum Saarlouis-Dillingen
      • Homburg, Germany
        • Universitaetsklinikum des Saarlandes
    • Saarland
      • Saarbruecken, Saarland, Germany, 66119
        • Klinikum Saarbruecken

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients admitted to a hospital in the Saarland region with ST elevation myocardial infarction, in the last 24 hours.

Description

Inclusion Criteria:

  • signed informed consent

Exclusion Criteria:

  • age < 18 years
  • missing informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of reperfusion therapies
Time Frame: 24 hours
Describe hospital daily routine in Germany
24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time before reperfusion therapy
Time Frame: 24 hours
pre-hospital time, intrahospital time, transfer time
24 hours
In-hospital mortality
Time Frame: 24 hours
Describe mortality before discharge
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Stiftung Institut fuer Herzinfarktforschung

Collaborators

Ministry of Social Affairs, Health, Women and Family of Saarland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2016

Primary Completion (Actual)

July 19, 2018

Study Completion (Actual)

March 29, 2023

Study Registration Dates

First Submitted

September 5, 2016

First Submitted That Met QC Criteria

November 8, 2016

First Posted (Estimate)

November 11, 2016

Study Record Updates

Last Update Posted (Actual)

April 14, 2023

Last Update Submitted That Met QC Criteria

April 11, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MIR-SL

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe